However, no significant differences were observed across CCR quartile groups regarding tumor diameter, serum creatinine levels, cystatin C levels, PA levels, ER status, PR status, HER2 status, Ki67 expression levels, or treatment modalities (surgery, targeted therapy, chemotherapy, radiotherapy, endocrine therapy). This evidence concerns the gene CST3 and neoplasm.